Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39655
NL-OMON39655
Completed
Phase 3

Towards a better trauma treatment for older adults: From comparative research to actual implementation. - NET WITH OLDER ADULTS

Stichting Centrum 45 (Oegstgeest)0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPsychotraumaPost Traumatic Stress Disorder10002861

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Psychotrauma
Sponsor
Stichting Centrum 45 (Oegstgeest)
Enrollment
80
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Stichting Centrum 45 (Oegstgeest)

Eligibility Criteria

Inclusion Criteria

  • •Patients of Foundation Centrum '45 and Sinai Centre, older than 55 years of age,
  • •with a DSM\-IV classification of (full or subthreshold) Post Traumatic Stress Disorder
  • •and a treatment indication of individual outpatient trauma focused Psychotherapy, without the need for assistance of interpreters

Exclusion Criteria

  • •Substance dependence
  • •Remittance of substance dependence should be at least 3 months;
  • •Psychotic disorder
  • •Current manic or bipolar disorder
  • •Severe depressive disorder (with suicidal or psychotic symptoms)
  • •Cognitive impairments or cognitive disorder;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
ET with older adults.NOVO: NET Onderzoek Voor ouderen.Post Traumatic Stress Disorder (PTSD) with older adults (> 55 years of age).Posttraumatische stressstoornis (PTSS) bij ouderen (55+).
NL-OMON26535Foundation Centrum '45Rijnzichtweg 35, 2342 AX OegstgeestandNienoord 5, 1112 XE Diemen80
Active, not recruiting
Not Applicable
Trauma-focused therapy for older adults: A clinical case seriesTrauma-focused therapies to reduce post-traumatic stress symptomsMental and Behavioural Disorders
ISRCTN51593856niversity of Manchester6
Active, not recruiting
Not Applicable
Curative and palliative treatment of adults aged > 60 years with AML.A randomised trial by OSHO on the role of (1) early intensification {OSHO protocol} vs. common standard arm of German AML Intergroup Study, (2) allografting as consolidative immunotherapy vs. a second consolidation course in elderly patients,(3) prospective evaluation of the decision between curative and palliative treatment-intention. - AML 2004 OSHO #069Acute myelogenous leukemia
EUCTR2005-002833-10-ATGerman Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a330
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.
EUCTR2016-002272-27-BESaarland University388
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2016-002272-27-ATSaarland University388